Search

everythinglearnresearchcommunity

for

Search:↓

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Basal cell carcinoma shows keratin patterns similar to hair follicle structures.

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Vitamin D receptor gene changes don't affect alopecia areata risk.

No clear link between androgen receptor variation and hair loss, but more research needed.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

A new mutation in the HR gene causes hair loss in a specific family.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.